Browsing "Endocrinology & Metabolism" by Keyword : Type 2 diabetes mellitus
Showing results 1 to 9 of 9
| Pub Year | | Title | Author(s) |
| 2011 | | 2011 Clinical Practice Guidelines for Type 2 Diabetes in Korea | 김혜진 |
| 2018 | | Association between sodium glucose co-transporter 2 inhibitors and a reduced risk of heart failure in patients with type 2 diabetes mellitus: a real-world nationwide population-based cohort study | 김대중, 김혜진, 이관우, 한승진 |
| 2018 | | Comparative Cardiovascular Risks of Dipeptidyl Peptidase-4 Inhibitors: Analyses of Real-world Data in Korea | 김대중, 하경화 |
| 2020 | | Comparison of heart failure risk and medical costs between patients with type 2 diabetes mellitus treated with dapagliflozin and dipeptidyl peptidase-4 inhibitors: a nationwide population-based cohort study | 김혜진 |
| 2009 | | Effects of Adding ω-3 Fatty Acids to Simvastatin on Lipids, Lipoprotein Size and Subspecies in Type 2 Diabetes Mellitus with Hypertriglyceridemia | 김대중, 김혜진, 한승진 |
| 2014 | | Glucose Lowering Effect of SGLT2 Inhibitors: A Review of Clinical Studies | 김혜진 |
| 2005 | | Resurvey of Alternative Medicine in Korean Type 2 Diabetes Mellitus after 10 Years | 이관우 |
| 2022 | | Sodium–glucose cotransporter 2 inhibitors do not increase the risk of fractures in real-world clinical practice in Korea: A national observational cohort study | 김대중, 최용준, 하경화 |
| 2018 | | Urinary Pentosidine levels negatively associates with trabecular bone scores in patients with type 2 diabetes mellitus | 정윤석, 최용준 |
1
